Integrated DNA Technologies (IDT) has launched the Collab Network Program, an inaugural program between next generation sequencing (NGS) providers.
According to a press release, the netowrk will give members the ability to “bolster collaborations to drive new discoveries…drive the development of new products, and invest in the next generation of researchers.”
“Now more than ever, collaborating with research partners who are united in a shared mission to accelerate the pace of genomics is becoming increasingly critical to advancing the future of medicine,” said Demaris Mills, president at IDT, in a statement. “Our current roster of Collab Network members represents some of the industry’s most disruptive companies who are leading the charge in technology and innovation, as well as genomics developers who are well-respected in their areas of research.
Members will include Catalytic Data Science, Complete Genomics, Element Biosciences, Geneseeq Technology, Helix, MLL Munich Leukemia Laboratory, Novogene, Opentrons Robotics, PerkinElmer, Psomagen, Singular Genomics, Sistemas Genomicos and Ultima Genomics.
IDT delivers technologies for genomics applications such as next generation sequencing, CRISPR genome editing, synthetic biology, digital PCR and RNA interference, a press release said.
The program will also feature research grant opportunities, with more details announced later this year.
In December, IDT invested in NGS research assays from Invitae Corporation in a deal worth $48 million.
